Proof of Concept Human Study: Dietary Intervention to Modify Intestinal Inflammation in IBD

NCT05867537 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-03-30

No results posted yet for this study

Summary

The objective of this clinical study is to demonstrate efficacy and feasibility of a long-term dietary intervention to modify intestinal inflammation in high-risk patient cohorts. To this end a 78 weeks wheat protein-free diet will be administered in patients with inflammatory bowel disease (IBD) with and without associated primary sclerosing cholangitis (PSC-IBD).

Conditions

  • Reduction of Intestinal Inflammatory Activity

Interventions

DIETARY_SUPPLEMENT

Gluten-free diet

Implementation a 78-week dietary intervention to patients with ulcerative colitis, crohn´s disease and UC patients with associated PSC (PSC-IBD).

Sponsors & Collaborators

  • University Medical Centre Schleswig-Holstein

    collaborator UNKNOWN
  • Lithuanian University of Health Sciences

    collaborator OTHER
  • University Medical Center Groningen, Netherland

    collaborator UNKNOWN
  • Weizmann Institute of Science, Israel

    collaborator UNKNOWN
  • Catholic University of the Sacred Heart

    collaborator OTHER
  • Eurice European Research and project office GMBH, Germany

    collaborator UNKNOWN
  • Orebro University, Sweden

    collaborator UNKNOWN
  • Region Capital Denmark

    collaborator OTHER
  • European Federation of Crohn´s and Ulcerative Colitis Associations, Belgium

    collaborator UNKNOWN
  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-18
Primary Completion
2028-01-31
Completion
2028-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05867537 on ClinicalTrials.gov